Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study

OBJECTIVES: We explored efficacy and safety of IVIg as first-line treatment in patients with an idiopathic inflammatory myopathy. METHODS: In this investigator-initiated phase 2 open-label study, we included 20 adults with a newly diagnosed, biopsy-proven idiopathic inflammatory myopathy, and a dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Johan, Eftimov, Filip, Verhamme, Camiel, Brusse, Esther, Hoogendijk, Jessica E, Saris, Christiaan G J, Raaphorst, Joost, De Haan, Rob J, van Schaik, Ivo N, Aronica, Eleonora, de Visser, Marianne, van der Kooi, Anneke J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023983/
https://www.ncbi.nlm.nih.gov/pubmed/33099648
http://dx.doi.org/10.1093/rheumatology/keaa459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023983/
https://www.ncbi.nlm.nih.gov/pubmed/33099648
http://dx.doi.org/10.1093/rheumatology/keaa459

Ejemplares similares